Solara Active gets EIR from USFDA for Mangalore facility

09 Nov 2018 Evaluate

Solara Active Pharma Sciences has completed USFDA inspection at its multi-product API facility in Mangalore. As part of GMP compliance audit, the company has received Establishment Inspection Report (EIR) from USFDA, thereby confirming the closure of the inspection in July 2018.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

540.00 9.95 (1.88%)
03-Apr-2025 10:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...